HomeAI · summaries
Storia in 5 fonti
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Hims & Hers falls 8% after Novo's legal threat. Here's the latest
Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"
- ·
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
- ·
ft.com
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy
- ·
Hims & Hers pulls copycat weight-loss pill after threats of legal action
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.
- ·
fortune.com
Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune
The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.
- ·
Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market
Danish group’s challenges mount despite winning reprieve after Hims & Hers withdraws plan to sell copycat Wegovy pill
- ·
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
- ·
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.
- ·
Novo Nordisk sues Hims & Hers over copycat weight-loss drugs
Shares in US company fall 16% after FDA announces investigation into unregulated medication
- ·
upi.com
Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com
Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.
- ·
bbc.com
Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".